Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Randomized, Double Dummy, Parallel Arm, Placebo and Active Controlled, Double Blind, Study of the Safety and Efficacy of PRX167700 as Monotherapy in Adults with Moderate to Severe Knee Pain Due to Osteoarthritis who are Inappropriate for Oral Non steroidal Anti inflammatory Therapy.

Next Previous
Search
Trial Profile

A Randomized, Double Dummy, Parallel Arm, Placebo and Active Controlled, Double Blind, Study of the Safety and Efficacy of PRX167700 as Monotherapy in Adults with Moderate to Severe Knee Pain Due to Osteoarthritis who are Inappropriate for Oral Non steroidal Anti inflammatory Therapy.

Status: Recruiting
Phase of Trial: Phase II

Latest Information Update: 30 Jul 2020

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs PRX 167700 (Primary) ; Tramadol
  • Indications Pain
  • Focus Therapeutic Use
  • Sponsors Proximagen

Most Recent Events

  • 30 Jul 2020 This trial has been discontinued in United Kingdom
  • 18 Jun 2019 New trial record

You need to be a logged in or subscribed to view this content Request demo (opens in a new window)

If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top